Bladder Cancer News and Research

Latest Bladder Cancer News and Research

Comparative study of ileocecal vs. ileal neobladders in radical cystectomy patients

The use of orthotopic urinary diversion has gained increasing popularity in the past 20 years.

14 Jun 2006

Reovirus could be used to treat many forms of advanced cancer

An experimental drug called Reolysin may give hope to patients suffering from advanced cancers, according to research presented at this year's meeting of the American Society of Clinical Oncology (ASCO).

8 Jun 2006

Comparative study of ileocecal vs. ileal neobladders in radical cystectomy patients

The use of orthotopic urinary diversion has gained increasing popularity in the past 20 years.

18 May 2006

Dietary folate intake may decrease risk of bladder cancer

Genetic alterations, epigenetic events and environmental exposures all contribute to the development of bladder cancer.

10 May 2006

MDCT urography shows potential for detecting bladder cancer without surgery

MDCT urography is a promising technique for detecting bladder tumors both with and without contrast material, helping patients avoid an invasive test, according to a new study by researchers from the University of Michigan Health System in Ann Arbor, MI.

3 May 2006

Environmental scientists identify new culprits in the cancer equation

In the granite-rich region of Western North Carolina, taking a daily shower could pose a risk of developing lung cancer. So could working from home every day. That's because granite emits a carcinogenic gas, radon.

13 Apr 2006

First human recipients of laboratory-grown organs

The first human recipients of laboratory-grown organs were by Anthony Atala, M.D., director of the Institute for Regenerative Medicine at Wake Forest University School of Medicine. In The Lancet, Atala describes long-term success in children and teenagers who received bladders grown from their own cells.

4 Apr 2006

Delaying urgery decreases survival for bladder cancer patients

Bladder cancer patients whose surgery was delayed for more than three months after their diagnosis were more likely to die from their disease than patients whose surgery was performed sooner, according to a study by researchers at the University of Michigan Comprehensive Cancer Center.

4 Apr 2006

Serum tumor markers predict extravesical disease in clinical stage T2 bladder cancer

Bladder cancer clinical staging is notoriously poor in patients with muscle invasive disease.

31 Mar 2006

Anti-cancer drugs based on platinum

Researchers at Virginia Commonwealth University's Massey Cancer Center have created a new platinum-based, anti-cancer agent able to overcome acquired drug resistance by first modifying the way it is absorbed into cancer cells and then attacking the DNA of those cancer cells.

6 Jan 2006

HRAS mutation analysis in Costello Syndrome

Gene mutations in the HRAS sequence are present in most patients affected with Costello syndrome, according to a new study in the American Journal of Medical Genetics. The mutations occurred de novo in patients, meaning, they were not observed in their parents' genes.

5 Dec 2005

Simple urine test detects bladder cancer

According to Italian researchers a simple and accurate urine test can detect bladder cancer early and they say the test should be used on smokers and others prone to the disease.

26 Oct 2005

Measurement of telomerase activity in urine appears useful for detection of bladder cancer in men

The incidence of human bladder cancer has greatly increased over the last few decades, with more than 60,000 new cases diagnosed each year in the United States alone, and now represents the 4th most common malignancy in men and the 10th most common in women, according to background information in the article.

25 Oct 2005

No evidence of a "safe" threshold with environmental toxins

Four of the most widespread environmental toxins - lead, trihalomethanes (found in drinking water), ionizing radiation from indoor radon gas, and tobacco smoke - can cause serious damage to health even at very low levels, say researchers in the open access journal PLoS Medicine.

18 Oct 2005

Strategic analyses of European In-Vitro cancer diagnostics market - Cancer research yields promising results

Every year, nearly one in four Europeans - a total of almost one million people - dies from cancer, giving Europe the dubious distinction of having amongst the highest cancer-related mortality rates in the world. Even as cancer remains a difficult disease to diagnose, often resulting in either poor diagnosis or misdiagnosis, the number of new cancer cases is set to double by 2020.

2 Aug 2005

Pregnancy fears on drinking water byproducts may be overstated

Fears that chemical byproducts resulting from purifying drinking water with chlorine boost the chances that pregnant women will miscarry were not supported by the results of a major new study. If such threats exist at all, which is uncertain, they likely are modest, it concludes.

1 Aug 2005

Broccoli may help prevent bladder cancer

Researchers have isolated compounds from the vegetable broccoli that they believe may help prevent or slow the progress of bladder cancer.

28 Jul 2005

Clear survival benefit for patients who have high-risk cancer surgeries at hospitals that commonly perform the procedures

Choosing a hospital that either performs many cystectomies--the surgical removal of the urinary bladder - or has a high nurse-to-patient ratio minimizes post-operative complications after the procedure, according to a new study.

25 Jul 2005

British men refuse to recognise they are fat

A new survey by Cancer Research UK, released to launch their Man Alive Campaign, is suggesting that 25% of British men are "in denial" about their waist measurement, and most men, when questioned were unaware that being overweight, obese, or inactive, increases the risk of cancer.

4 Jul 2005

Bioniche Life Sciences granted European patent

Bioniche Life Sciences has announced that it has had another patent granted on its core technology: Mycobacterial Cell Wall-DNA Complex (MCC). The European Patent Organization (EPO) granted the patent: - "Composition and Method for Inducing Apoptosis in Prostate Cancer Cells" (EPO1165106)

30 May 2005